November 12 – 16, 2023 | Houston, Texas

The conference will bring together cancer researchers, RNA scientists, clinicians, and drug development companies. The program’s main goals are to accelerate the translation of fundamental advances into novel clinical cancer therapeutics, and to encourage and support junior investigators/trainees, women, and minority scientists to continue pursuing research at the intersection of RNA and cancer.